Portola Pharmaceuticals Inc Net Income per Employee (PTLA), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Portola Pharmaceuticals inc   (NASDAQ: PTLA)
 

Portola Pharmaceuticals Inc Net Income per Employee

PTLA's Quarterly Results, Trends, Rankings, Statistics
Portola Pharmaceuticals Inc recorded a cumulative net loss of $-284 million during 12 month ending in the first quarter 2020.
The Healthcare sector has seen employees of 244 other companies achieving higher income per employee. While Portola Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 3890.


What is Income per Employee Ratio?






PTLA Net Income per Employee (Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -800,992 -827,333 -805,328 -866,203 -972,119
PTLA's Total Ranking # 3890 # 0 # 0 # 0 # 0
Seq. Net Income Change - - - - -


PTLA Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 245
Healthcare Sector # 593
Overall Market # 3890

Net Income per Employee Statistics
High Average Low
$ -387,359 $ -741,742 $ -990,237
(Dec 31 2014)   (Dec 31 2018)







Companies with similar Income per Employee for 12 month ending Mar 31 2020, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2020Number of Employees Mar 31 2020


Date modified: 2026-08-29T17:19:42+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.